IV: $$

Spectrum of Activity

General Information

  • Cutaneous Abscesses, Furuncles, Carbuncles, and Boils, Moderate, with or without cellulitis: IV (inpatient)
  • Cellulitis Without Drainable Abscess: Moderate-severe (inpatients): IV
  • Periorbital Cellulitis Traumatic: Moderate-Severe
  • Cervical Adenitis: Moderate to Severe (IV)
  • Septic arthritis: Child
  • Osteomyelitis (acute): Child
  • Puncture wound of foot no sneakers

Telephone Exceptional Access Program Product (injection)

Telephone EAP Criteria:

Dosage Form 1g/vial injection

For treatment of infections susceptible to cefazolin

Standard Approval Duration: As requested up to 5 years

Frequency not defined

  • Cardiovascular: Localized phlebitis
  • Central nervous system: Seizure
  • Dermatologic: Pruritus, skin rash, Stevens-Johnson syndrome
  • Gastrointestinal: Abdominal cramps, anorexia, diarrhea, nausea, oral candidiasis, pseudomembranous colitis, vomiting
  • Genitourinary: Vaginitis
  • Hepatic: Hepatitis, increased serum transaminases
  • Hematologic: Eosinophilia, leukopenia, neutropenia, thrombocythemia, thrombocytopenia
  • Hypersensitivity: Anaphylaxis
  • Local: Pain at injection site
  • Renal: Increased blood urea nitrogen, increased serum creatinine, renal failure
  • Miscellaneous: Fever
  • Renal function periodically when used in combination with other nephrotoxic drugs, hepatic function tests, and CBC
  • Prothrombin time in patients at risk
  • Number and type of stools/day for diarrhea
  • Monitor for signs of anaphylaxis during first dose